Meeting the 2024 deadline for an international agreement on pandemic response may not happen; the Biden administration announces measures to counter restrictive state laws on abortion; cervical cancer incidence declines as more women receive the human papillomavirus vaccine.
Concerns Over Impending Deadline for Global Pandemic Accord
Director-general of the World Health Organization, Tedros Adhanom Ghebreyesus, PhD, MSc, is voicing apprehension regarding the approaching deadline for a global pandemic accord, according to Reuters. Additionally, he emphasizes the complexities involved in reaching a consensus on an international framework for pandemic response in 2024. This new pact and a series of updates to existing rules pertaining to pandemics are intended to be a comprehensive international agreement to shore up the world’s defenses against new pathogens after the COVID-19 pandemic.
Biden Administration Unveils New Abortion Initiatives on Roe v Wade Anniversary
On the anniversary of the Roe v Wade decision, the Biden administration has introduced a series of new initiatives aimed at supporting and protecting abortion rights, according to NBC News. President Biden's announcement came in response to the increasing challenges posed by restrictive state laws, reaffirming the administration's commitment to upholding reproductive rights. The initiatives signal a proactive approach to safeguarding access to abortion services and addressing the ongoing legal battles surrounding reproductive health care.
Cervical Cancer Increasing in Women Despite HPV Vaccine
New research suggests a positive correlation between the widespread administration of the human papillomavirus (HPV) vaccine and a significant decrease in cervical cancer cases among women, with rates falling fastest in women in their 20s, according to NBC News. However, cervical cancer incidence has been increasing in women in their 30s and early 40s, suggesting that not all women are similarly benefitting. As more individuals receive the vaccine, this development underscores the potential for further progress in preventing cervical cancer and related health complications.
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More